BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+4.86%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$721M
AUM Growth
+$721M
(+0.55%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
154
New
13
Increased
38
Reduced
45
Closed
14
Top Buys
| 1 |
Illumina
ILMN
|
$5.94M |
| 2 |
ENDP
Endo International plc
ENDP
|
$5.73M |
| 3 |
Cencora
COR
|
$5.32M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$5.21M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.21M |
Top Sells
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$18.9M |
| 2 |
Baxter International
BAX
|
$9.56M |
| 3 |
Centene
CNC
|
$9.48M |
| 4 |
LCI
Lannett Company, Inc.
LCI
|
$6.61M |
| 5 |
Molina Healthcare
MOH
|
$6.39M |
Sector Composition
| 1 | Healthcare | 90.06% |
| 2 | Financials | 0.8% |
| 3 | Industrials | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.4B
| $9.22M | 1.28% |
41,000
| – | – |
|
27
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.89M | 1.23% |
65,000
-36,000
| -36% | -$4.92M |
|
28
Ligand Pharmaceuticals
LGND
$3.15B
| $7.69M | 1.07% |
76,190
-16,970
| -18% | -$1.71M |
|
29
Perrigo
PRGO
$3.27B
| $7.39M | 1.03% |
40,000
+25,000
| +167% | +$4.62M |
|
30
Cigna
CI
$80.3B
| $7.29M | 1.01% |
45,000
| – | – |
|
31
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $7.23M | 1% |
250,000
+170,000
| +213% | +$4.91M |
|
32
Dr. Reddy's Laboratories
RDY
$11.8B
| $7.19M | 1% |
130,000
+30,000
| +30% | +$1.66M |
|
33
Boston Scientific
BSX
$156B
| $7.08M | 0.98% |
400,000
-4,000
| -1% | -$70.8K |
|
34
Tenet Healthcare
THC
$16.3B
| $7.06M | 0.98% |
121,950
+71,950
| +144% | +$4.16M |
|
35
Alkermes
ALKS
$4.78B
| $7.05M | 0.98% |
109,500
+23,000
| +27% | +$1.48M |
|
36
Ionis Pharmaceuticals
IONS
$6.79B
| $7.02M | 0.97% |
122,000
-25,000
| -17% | -$1.44M |
|
|
MDVN
37
DELISTED
MEDIVATION, INC.
MDVN
| $7M | 0.97% |
61,300
+7,000
| +13% | +$799K |
|
|
SHPG
38
DELISTED
Shire pic
SHPG
| $6.71M | 0.93% |
27,800
+16,800
| +153% | +$4.06M |
|
39
Intuitive Surgical
ISRG
$170B
| $6.57M | 0.91% |
13,550
| – | – |
|
40
Alnylam Pharmaceuticals
ALNY
$58.5B
| $6.47M | 0.9% |
54,000
-10,000
| -16% | -$1.2M |
|
|
RCPT
41
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $6.46M | 0.9% |
34,000
-14,000
| -29% | -$2.66M |
|
|
42
Cencora
COR
$56.5B
| $6.38M | 0.89% |
60,000
+50,000
| +500% | +$5.32M |
|
43
Incyte
INCY
$16.5B
| $5.94M | 0.82% |
57,000
-31,352
| -35% | -$3.27M |
|
|
MNK
44
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.89M | 0.82% |
50,000
-20,000
| -29% | -$2.35M |
|
45
Novavax
NVAX
$1.21B
| $5.79M | 0.8% |
520,000
| – | – |
|
|
AET
46
DELISTED
Aetna Inc
AET
| $5.74M | 0.8% |
45,000
-14,000
| -24% | -$1.78M |
|
|
AKRX
47
DELISTED
Akorn, Inc.
AKRX
| $5.59M | 0.78% |
128,050
-16,950
| -12% | -$740K |
|
48
CVS Health
CVS
$92.8B
| $5.24M | 0.73% |
50,000
+20,000
| +67% | +$2.1M |
|
|
HZNP
49
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.21M | 0.72% |
+150,000
| New | +$5.21M |
|
|
BCR
50
DELISTED
CR Bard Inc.
BCR
| $5.12M | 0.71% |
30,000
| – | – |
|